GLP-1 medications have become widely available online, but patients are frequently met with confusing pricing structures, unrealistic expectations, and little to no support once treatment begins
GLP-1 secretion may be normal or modestly reduced in type 2 diabetes, with considerable variability across studies
10.1111/j.1463-1326.2011.01428.x 44
Zepbound runs 2.5 to 15 mg), usually for maintenance or appetite control
Severe Digestive Complications Despite being newer, tirzepatide drugs are already associated with: Gastroparesis (stomach paralysis) Ileus (intestinal blockage) Severe persistent vomiting Gastric outlet obstruction Cyclic vomiting syndrome The mechanism is similar to semaglutide: excessive slowing of gastric emptying
Laboratories that standardize these variables and record them consistently often see improved run to run comparability